Mantegazza R - Search Results

1

Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis.

Howard JF Jr, Bril V, Burns TM, Mantegazza R, Bilinska M, Szczudlik A, Beydoun S, Garrido FJRR, Piehl F, Rottoli M, Van Damme P, Vu T, Evoli A, Freimer M, Mozaffar T, Ward ES, Dreier T, Ulrichts P, Verschueren K, Guglietta A, de Haard H, Leupin N, Verschuuren JJGM; Efgartigimod MG Study Group. Howard JF Jr, et al. Among authors: mantegazza r. Neurology. 2019 Jun 4;92(23):e2661-e2673. doi: 10.1212/WNL.0000000000007600. Epub 2019 May 22. Neurology. 2019. PMID: 31118245 Free PMC article. Clinical Trial.

2

Prognosis of myasthenia gravis: a multicenter follow-up study of 844 patients.

Beghi E, Antozzi C, Batocchi AP, Cornelio F, Cosi V, Evoli A, Lombardi M, Mantegazza R, Monticelli ML, Piccolo G, et al. Beghi E, et al. Among authors: mantegazza r. J Neurol Sci. 1991 Dec;106(2):213-20. doi: 10.1016/0022-510x(91)90260-e. J Neurol Sci. 1991. PMID: 1802969 Clinical Trial.

3

A short plasma exchange protocol is effective in severe myasthenia gravis.

Antozzi C, Gemma M, Regi B, Berta E, Confalonieri P, Peluchetti D, Mantegazza R, Baggi F, Marconi M, Fiacchino F, et al. Antozzi C, et al. Among authors: mantegazza r. J Neurol. 1991 Apr;238(2):103-7. doi: 10.1007/BF00315690. J Neurol. 1991. PMID: 1856735

4

Prospects for specific immunotherapy in myasthenia gravis.

Steinman L, Mantegazza R. Steinman L, et al. Among authors: mantegazza r. FASEB J. 1990 Jul;4(10):2726-31. doi: 10.1096/fasebj.4.10.2197152. FASEB J. 1990. PMID: 2197152 Review.

5

A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy.

Mantegazza R, Beghi E, Pareyson D, Antozzi C, Peluchetti D, Sghirlanzoni A, Cosi V, Lombardi M, Piccolo G, Tonali P, et al. Mantegazza R, et al. J Neurol. 1990 Oct;237(6):339-44. doi: 10.1007/BF00315656. J Neurol. 1990. PMID: 2277266 Clinical Trial.

6

Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis.

Mantegazza R, Antozzi C, Peluchetti D, Sghirlanzoni A, Cornelio F. Mantegazza R, et al. J Neurol. 1988 Nov;235(8):449-53. doi: 10.1007/BF00314245. J Neurol. 1988. PMID: 3062134 Clinical Trial.

7

New antigen for antibody detection in myasthenia gravis.

Gotti C, Mantegazza R, Clementi F. Gotti C, et al. Among authors: mantegazza r. Neurology. 1984 Mar;34(3):374-7. doi: 10.1212/wnl.34.3.374. Neurology. 1984. PMID: 6538281

8

Removal of antiacetylcholine receptor antibodies by protein-A immunoadsorption in myasthenia gravis.

Berta E, Confalonieri P, Simoncini O, Bernardi G, Busnach G, Mantegazza R, Cornelio F, Antozzi C. Berta E, et al. Among authors: mantegazza r. Int J Artif Organs. 1994 Nov;17(11):603-8. Int J Artif Organs. 1994. PMID: 7744521 Clinical Trial.

9

Immune activation in myasthenia gravis: soluble interleukin-2 receptor, interferon-gamma and tumor necrosis factor-alpha levels in patients' serum.

Confalonieri P, Antozzi C, Cornelio F, Simoncini O, Mantegazza R. Confalonieri P, et al. Among authors: mantegazza r. J Neuroimmunol. 1993 Oct;48(1):33-6. doi: 10.1016/0165-5728(93)90055-4. J Neuroimmunol. 1993. PMID: 8227305

10

IL-1 genes in myasthenia gravis: IL-1A -889 polymorphism associated with sex and age of disease onset.

Sciacca FL, Ferri C, Veglia F, Andreetta F, Mantegazza R, Cornelio F, Franciotta D, Piccolo G, Cosi V, Batocchi AP, Evoli A, Grimaldi LM. Sciacca FL, et al. Among authors: mantegazza r. J Neuroimmunol. 2002 Jan;122(1-2):94-9. doi: 10.1016/s0165-5728(01)00449-0. J Neuroimmunol. 2002. PMID: 11777547

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

342 results

Search Page

Filters